Haematological Disorders Nutritional, Metabolic, Endocrine Anaemia
Conditions
Interventions
Sponsors
Shalina Healthcare
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Male or female (=12 years) suffering from iron deficiency anaemia having hemoglobin between 9 to 12 g/dl. Patients or parents willing to provide written informed consent to use personal and/or health data prior to the entry into the study.
Exclusion criteria
Exclusion criteria: Anaemia not linked to iron deficiency. Hemoglobin less than 9 g/dL. Allergy to iron derivatives. Any medical disorder like diabetes or tuberculosis (TB), viral hepatitis cirrhosis, renal disease, autoimmune disease. Those who had received parenteral iron treatment earlier within 3 months before the start of the study. Patients with history of chronic blood loss. Alcohol abuse within past 6 months. Hemosiderosis, hemochromatosis or other iron storage disorders. Patients with a history or present illness that is a malignant tumor or autoimmune disease. Patients who underwent oral administration of an iron preparation (including an over-the-counter drug or supplement) within 4 weeks before the screening.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hemoglobin measures at baseline, 3 weeks, and 8 weeks after treatment to determine efficacy | — |
Secondary
| Measure | Time frame |
|---|---|
| Ferritin levels Physician consultation and examination to determine General wellness (weight correction, weakness/lethargy) at baseline and 8 weeks Physician consultation and examination to determine side effects (constipation, nausea, organoleptic and others) | — |
Countries
Ghana
Contacts
Public ContactRahul Mandlik
Head medical affairs
Outcome results
None listed